News

March 3, 2021March 3, 2021

Group Completes First Dose of Stem Cells for Bradykinesia

News

IMAC Holdings has completed dosing the first group of participants in a Phase 1 clinical trial evaluating its investigational umbilical cord-derived mesenchymal stem cells (MSCs) as a potential treatment for ... Read more

March 3, 2021March 3, 2021

Efficacy of Deep Brain Stimulation Depends on Type, Levodopa Response

News

The impact of deep brain stimulation (DBS) in improving motor function in people with Parkinson’s disease may be related to a patient’s response to levodopa therapy, and to the type ... Read more

March 2, 2021March 2, 2021

Plant Compound Berberine May Boost Brain Function

News

Scientists have found that berberine, a natural plant compound that has been used in China as an over-the-counter medicine for diarrhea, can promote the production of l-dopa, a precursor of ... Read more

March 2, 2021March 2, 2021

Medication Adherence Didn’t Affect Patients’ Life Quality in Small Study

News

People with Parkinson’s disease who failed to take their medication as prescribed — meaning, were nonadherent — showed no difference in measures of health-related quality of life (HRQoL) than those who ... Read more

March 1, 2021March 1, 2021

Changes to Nerve Cell Membrane May Promote Alpha-synuclein’s Toxic Turn

News

Changes in the composition of fat molecules on the membranes of nerve cells appear to change how the alpha-synuclein protein interacts with these same cell membranes, possibly promoting the aggregation that characterizes ... Read more

March 1, 2021March 2, 2021

Blood Glucose Levels Appear to Affect Motor Skills and Their Decline

News

Abnormal blood sugar (glucose) levels, either lower or higher than the norm, appears to be linked with a faster progression of motor difficulties in people with Parkinson’s disease, research suggests. The ... Read more

February 26, 2021February 26, 2021

Newronika’s AlphaDBS System Earns CE Mark in Europe

News

Newronika‘s AlphaDBS, an innovative deep brain stimulation (DBS) system being evaluated in patients with Parkinson’s disease, has received CE Mark approval in Europe. The CE Mark is a seal of ... Read more

February 26, 2021February 26, 2021

Biogen, Sangamo to Develop Novel Gene Therapies

News

Biogen and Sangamo Therapeutics have begun a collaboration to develop and commercialize gene therapies for Parkinson’s and Alzheimer’s diseases, as well as an undisclosed neuromuscular disease. The five-year collaboration will join ... Read more

February 25, 2021February 25, 2021

Project to Test Virtual Reality Weight-Shifting Strategies for Gait Freezing

News

A three-year U.K. project will investigate whether weight-shifting strategies, developed and tested using virtual reality, can help people with Parkinson’s disease to overcome freezing of gait — when patients feel ... Read more

February 25, 2021February 25, 2021

Parkinson’s UK Invests Up to £800,000 in New Trial Testing GDNF

News

Parkinson’s UK is paving the way for a future clinical trial that will continue to test a naturally occurring protein, the glial cell line-derived neurotrophic factor or GDNF, as a ... Read more